Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update by Johnson, JA, Caudle, KE, Gong, L, Whirl‐Carrillo, M, Stein, CM, Scott, SA, Lee, MT, Gage, BF, Kimmel, SE, Perera, MA, Anderson, JL, Pirmohamed, M, Klein, TE, Limdi, NA, Cavallari, LH, Wadelius, M

Get full text

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update by Ramsey, L B, Johnson, S G, Caudle, K E, Haidar, C E, Voora, D, Wilke, R A, Maxwell, W D, McLeod, H L, Krauss, R M, Roden, D M, Feng, Q, Cooper-DeHoff, R M, Gong, L, Klein, T E, Wadelius, M, Niemi, M

Get full text

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing by Johnson, J A, Gong, L, Whirl‐Carrillo, M, Gage, B F, Scott, S A, Stein, C M, Anderson, J L, Kimmel, S E, Lee, M T M, Pirmohamed, M, Wadelius, M, Klein, T E, Altman, R B

Get full text

Phenotype Standardization for Statin-Induced Myotoxicity by Alfirevic, A, Neely, D, Armitage, J, Chinoy, H, Cooper, R G, Laaksonen, R, Carr, D F, Bloch, K M, Fahy, J, Hanson, A, Yue, Q-Y, Wadelius, M, Maitland-van Der Zee, A H, Voora, D, Psaty, B M, Palmer, C N A, Pirmohamed, M

Get full text

The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy by Wilke, R A, Ramsey, L B, Johnson, S G, Maxwell, W D, McLeod, H L, Voora, D, Krauss, R M, Roden, D M, Feng, Q, Cooper-DeHoff, R M, Gong, L, Klein, T E, Wadelius, M, Niemi, M

Get full text

Integration of Genetic, Clinical, and INR Data to Refine Warfarin Dosing by Lenzini, P, Wadelius, M, Kimmel, S, Anderson, J L, Jorgensen, A L, Pirmohamed, M, Caldwell, M D, Limdi, N, Burmester, J K, Dowd, M B, Angchaisuksiri, P, Bass, A R, Chen, J, Eriksson, N, Rane, A, Lindh, J D, Carlquist, J F, Horne, B D, Grice, G, Milligan, P E, Eby, C, Shin, J, Kim, H, Kurnik, D, Stein, C M, McMillin, G, Pendleton, R C, Berg, R L, Deloukas, P, Gage, B F

Get full text

Time to onset of bisphosphonate‐related osteonecrosis of the jaws: a multicentre retrospective cohort study by Fung, PPL, Bedogni, G, Bedogni, A, Petrie, A, Porter, S, Campisi, G, Bagan, J, Fusco, V, Saia, G, Acham, S, Musto, P, Petrucci, MT, Diz, P, Colella, G, Mignogna, MD, Pentenero, M, Arduino, P, Lodi, G, Maiorana, C, Manfredi, M, Hallberg, P, Wadelius, M, Takaoka, K, Leung, YY, Bonacina, R, Schiødt, M, Lakatos, P, Taylor, T, De Riu, G, Favini, G, Rogers, SN, Pirmohamed, M, Nicoletti, P, Fedele, S, López‐Cedrún, Jose L, Madsen, Sanne, Sadile, Gennaro, Leuci, Stefania, Mirelli, Cristina, Conti, Giulio, Maiavacca, Rita, Urade, Masahiro, Kishimoto, Hiromitsu, Okui, Shin, Zushi, Yusuke, Yamamura, Michiyo, Yoshikawa, Kyohei, Mansueto, Giovanna, Magnusson, Patrik KE, Popat, Shina, Kirnbauer, Barbara, Obermayer‐Pietsch, Barbara, Jakse, Norbert, Mariani, Umberto, Martini, Valeria, Fasciolo, Antonella, Martino, Iolanda, Alessio, Manuela, Sanromán, Jacinto F, Grammatico, Sara, Siniscalchi, Giovanni, Itro, Angelo, Balla, Bernadett, Kosa, Janos P, Vaszilko, Mihaly, Lo, John, Besi, Eleni, D'Aiuto, Francesco, Yong, Kwee, Donos, Nikos, Mercadante, Valeria, Stein, Robert, D'Sa, Shirley, Varoni, Elena, Soma, Damiano, Meloni, Silvio, Evely, Jane, Hanson, Anita, Giancola, Francesco, Di Fede, Olga, Panzarella, Vera, Bettini, Giordana, Merigo, Elisabetta, Mergoni, Giovanni, Vescovi, Paolo, Gandolfo, Sergio, Marino, Roberto, Berrone, Mattia, Gambino, Alessio, Menegatti, Elisa, Broccoletti, Roberto, Hens, Elena, Bagan, Leticia

Get full text

Identification of risk factors for adverse drug reactions in a pharmacovigilance database by Attelind, S., Eriksson, N., Sundström, A., Wadelius, M., Hallberg, P.

Get full text

A Proposal for an Individualized Pharmacogenetics-Based Warfarin Initiation Dose Regimen for Patients Commencing Anticoagulation Therapy by Avery, P J, Jorgensen, A, Hamberg, A K, Wadelius, M, Pirmohamed, M, Kamali, F

Get full text

Regulatory Variants Other Than VKORC1 rs9923231 May Explain The Effect on Warfarin Dose by Cavalli, M, Pan, G, Wallerman, O, Wadelius, M, Wadelius, C

Get full text

A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy by Hamberg, A‐K, Dahl, M‐L, Barban, M, Scordo, M G, Wadelius, M, Pengo, V, Padrini, R, Jonsson, E N

Get full text

Technological readiness and implementation of genomic‐driven precision medicine for complex diseases by Franks, P. W., Melén, E., Friedman, M., Sundström, J., Kockum, I., Klareskog, L., Almqvist, C., Bergen, S. E., Czene, K., Hägg, S., Hall, P., Johnell, K., Malarstig, A., Catrina, A., Hagström, H., Benson, M., Gustav Smith, J., Gomez, M. F, Orho‐Melander, M., Jacobsson, B., Halfvarson, J., Repsilber, D., Oresic, M., Jern, C., Melin, B., Ohlsson, C., Fall, T., Rönnblom, L., Wadelius, M., Nordmark, G., Johansson, Å., Rosenquist, R., Sullivan, P. F.

Get full text

Functional role of P-glycoprotein in the human blood-placental barrier by Mölsä, Melissa, Heikkinen, Tuija, Hakkola, Jukka, Hakala, Kristo, Wallerman, Ola, Wadelius, Mia, Wadelius, Claes, Laine, Kari

Get full text

A Pharmacometric Model Describing the Relationship Between Warfarin Dose and INR Response With Respect to Variations in CYP2C9, VKORC1, and Age by Hamberg, A‐K, Wadelius, M, Lindh, J D, Dahl, M L, Padrini, R, Deloukas, P, Rane, A, Jonsson, E N

Get full text

Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden by Verhoef, T I, Redekop, W K, Langenskiold, S, Kamali, F, Wadelius, M, Burnside, G, Maitland-van der Zee, A-H, Hughes, D A, Pirmohamed, M

Get full text

The largest prospective warfarin-treated cohort supports genetic forecasting (vol 113, pg 784, 2009) by Wadelius, M, Chen, LY, Lindh, JD

Get full text

Patients Benefit From Genetics-Guided Coumarin Anticoagulant Therapy by van der Zee, A H Maitland, Daly, A K, Kamali, F, Manolopoulous, V G, Verhoef, T I, Wadelius, M, de Boer, A, Pirmohamed, M

Get full text

Phenotype Standardization of Angioedema in the Head and Neck Region Caused by Agents Acting on the Angiotensin System by Wadelius, M, Marshall, S E, Islander, G, Nordang, L, Karawajczyk, M, Yue, Q-Y, Terreehorst, I, Baranova, E V, Hugosson, S, Sköldefors, K, Pirmohamed, M, Maitland-van der Zee, A-H, Alfirevic, A, Hallberg, P, Palmer, C N A

Get full text

Genome-Wide Association Study of Angioedema Induced by Ace Inhibitors or Arbs in Sweden by Wadelius, M, Eriksson, N, Johansson, C, Persson, M, Karawajczyk, M, Nordang, L, Islander, G, Hugosson, S, Axelsson, T, Yue, Q.-Y, Magnusson, P.K.E, Hallberg, P

Get full text

Influence of adenosine triphosphate and ABCB1 (MDR1) genotype on the P-glycoprotein-dependent transfer of saquinavir in the dually perfused human placenta by Rahi, M, Heikkinen, T, Hakkola, J, Hakala, K, Wallerman, O, Wadelius, M, Wadelius, C, Laine, K

Request full text